Breaking through: new approaches to combating solid tumors with CAR-T therapies
Live & Recorded on: Tuesday, December 7, 2021 | 11am ET / 8am PT | BD

This Fierce webinar will include input from biopharma researchers who are working on new CAR-T technologies aimed at solid tumors. They will discuss the challenges involved in designing and developing the next generation of CAR-Ts. Register Now.

Preparing for Phase 1: Strategies for success in advancing your drug to first-in-human trials
Wednesday, November 17, 2021 | 11am ET / 8am PT | Catalent

Companies can encounter a number of pitfalls on the path to moving a drug from preclinical to clinical trials. Understanding these hurdles—and properly preparing for them—can prevent a drug development program from stalling or, worse, stopping altogether. During this webinar, biopharma R&D professionals will review strategies for moving successfully and efficiently from preclinical studies to first-in-human trials. They will call upon their own experiences to provide advice that will help others in the industry navigate this crucial transition. Register Now.

The cell therapy divide - How to navigate the challenges of taking clinical-level manufacturing capacity up to commercial scale
Live & Recorded on: Tuesday, November 16, 2021 | 11am ET / 8am PT | Catalent

When your manufacturing process depends on healthcare professionals working with the patients to get the front-end and back-end of the processes exactly right, those professionals need to understand your process unequivocally. That may mean having a team of trainers to make that happen. We’ll discuss the challenges posed by this new wave of therapies and how the pioneers in the field are tackling them. Register Now.

How immune profiling can enhance the immuno-oncology treatment paradigm
Live & Recorded on: Thursday, November 11, 2021 | 11am ET / 8am PT | BD

During this Fierce webinar, experts in diagnostics, immunotherapy and oncology drug development will cover the latest advances in immune profiling, and provide advice on how biopharma companies can incorporate these developments into their R&D programs. Register Now.

Dynamic pediatric reference value distributions for plasma cytokines
Live & Recorded on: Wednesday, November 3, 2021 | 11am ET / 8am PT | Bio-Techne

In this webinar, attendees will learn about the CALIPER program and how it established a comprehensive database of pediatric RIs for over 180 clinical biomarkers, how the stratification of cytokine results based on age and/or sex specific RIs is expected to facilitate more accurate interpretation of cytokine expression patterns, and about Ella™, a multi-analyte immunoassay technology the CALIPER team is using to investigate pediatric cytokine profiles. Register Now.

Taking the “Clinic” Out of Clinical Trials - Bridging research and care with digital tools
Live & Recorded on: Tuesday, November 2, 2021 | 12pm ET / 9am PT | Huma

This webinar will bring together five industry leaders to provide their perspectives on how digital tools will ease some of the pain points in clinical trials and lead to the improvement in patient care. Register Now.

Clinical Adjudication Survey Results Revealed
Live & Recorded On: Tuesday, November 2, 2021 | 1pm ET / 10am PT | Bioclinica

In a recent survey, 89% of clinical adjudication users agreed clinical adjudication provides value to clinical trials. Why? Because using unbiased experts to evaluate a drug or device against predetermined criteria helps determine patient safety and clinical efficacy. Join two Bioclinica experts for a discussion of these and other survey results to understand how they could impact your studies. Register Now.

Launching a First Product in Europe - The Supply Chain Perspective
Live & Recorded On: Wednesday, October 27, 2021 | 11am ET / 8am PT | AIM


An efficient supply chain is critical to any first launch in Europe. This webinar will identify and address the critical aspects that companies must consider when creating a distribution and financial infrastructure in Europe.  Our expert panel will share their experiences, as well as discuss the key benchmarks and pitfalls on the journey to building the optimal supply chain infrastructure. Register Now.

Implementing Decentralized or Hybrid Trials – New roles, processes and technologies transforming clinical development
Live & Recorded on: Tuesday, October 26, 2021 | 11am ET / 8am PT | IQVIA

Understand what it takes to implement a Decentralized Trial (DCT), including new roles, processes, and new technologies. Register now to hear lessons learnt and Case Studies in delivering global DCTs. Register Now.

The Next-Generation of Antibody Libraries for Therapeutic Discovery
Live & Recorded on: Wednesday, October 20, 2021 | 2pm ET / 11am PT | Twist Bioscience

In this webinar, we discuss the latest in library synthesis technology, and its use to build innovative libraries that harness structural and developability features to cover a wide range of antibody drug targets. We show how these libraries enable the discovery of high-affinity drug-like antibodies, often without the need for affinity maturation. Register Now.

New ctDNA data in response monitoring
Live & Recorded on: Thursday, October 14, 2021 | 11am ET / 8am PT | Natera

Learn about the latest advances in leveraging bespoke ctDNA testing in clinical trials. Find out how Signatera has been applied in early stage and late stage disease. Dive into New published and presented data across multiple tumor types. Discover improvements to clinical trial design with Signatera including: identifying early relapsers, enriching for patients potentially most likely to respond to therapy, accelerating time to trial readout, predicting clinical outcomes as early as 6 weeks into treatment. Register Now.

The power of a digital thread in pharma
Live & Recorded On: Wednesday, October 13, 2021 | 11am ET / 8am PT | Accenture AWS Business Group

AWS and Accenture share how they help transform pharma manufacturing, supply chain and quality control processes to deliver more personalized products faster and improve the patient experience. Register Now.

Accelerating Clinical Development with Expanded Access
Live & Recorded On: Wednesday, October 13 | 1pm ET / 10am PT | Rho

Join this webinar to learn how Expanded Access can advance and accelerate development of products to treat serious conditions, including strategic considerations and the regulatory utility of data from Expanded Access programs. Register now.

Highly Potent API Drug Product Development and Manufacturing Using Micronization Technology
Live & Recorded On: Tuesday, October 12, 2021 | 11am ET / 8am PT | Catalent

Development of HPAPIs presents unique challenges for product containment and requires special consideration in equipment selection, operating procedures, and safety processes. This webinar will discuss how to classify HPAPIs in early development and share recommendations for safe product handling, from clinical manufacturing to commercialization. The speakers will also share the key advantages of using micronization technology for the development and manufacturing of HPAPIs. Register Now.

Building a robust FIH biologics regulatory CMC package
Live & Recorded On: Thursday, October 7, 2021 | 2pm ET / 11am PT | Thermo Fisher Scientific

Join us to learn how to develop a robust first-in-human (FIH) regulatory CMC package for recombinant biological molecules by integrating the following activities into your project plan: progressively developing knowledge of the molecule’s critical quality attributes to justify the manufacturing and control strategy, planning for continuing development, and identifying opportunities to enhance with scientific advice. Register Now.

Delivering Streamlined Processes and Customer-Centricity in the HLS Industry
Thursday, October 7, 2021 | 2pm BST / 9am ET | FinancialForce

Join this webinar to explore how running a customer-centric organization leads to organisational agility, process efficiency, and ultimately faster speed of innovation. Register now.

The Future of Genomics in Healthcare and Medicine
Live & Recorded On: Wednesday, October 6, 2021 | 1pm ET / 10am PT | SurveyHealthcareGlobus

In this webinar, you will learn physician’s current and expected futures use of genomic sequencing, the impact of genome sequencing on individual healthcare, views on how genome sequencing will change the practice of medicine, perspectives on physicians’ concerns about genome sequencing for their patients, and how genome sequencing is changing cancer treatment plans. Register Now.

What is the Future Landscape of Cell and Gene Therapies?
Wednesday, October 6, 2021 | 11am ET / 8am PT | Veristat

Favorable regulatory outcomes and a high demand for novel and on-demand cell and gene therapies has poised viral vector manufacturing for a significant jump. With new efficiencies on the horizon, what does this mean for the future of these therapies and their potential to treat a wider patient population? Register now.

Finding the right patients for clinical trials
Live & Recorded On: Tuesday, October 5, 2021 | 11am ET / 8am PT | uMed

We’ll explore the landscape of technologies and services that match patients to clinical trials, providing feedback from CRO executives who have experience with them. Topics include how innovative technology is being harnessed to extract information from electronic medical records in order to identify the most appropriate patients for clinical trials, best practices for using social media to match patients to clinical trials, and more. Register Now.

Nature Laughs at the Difficulties of Integration - An expert panel documents proven methods for solving ELN integration challenges
Live & Recorded on: Wednesday, October 3, 2021 | 11am ET / 8am PT | PerkinElmer

Pierre-Simon LaPlace, a famed French scientist, stated “nature laughs at the difficulties of integration.” We have assembled a panel of integration experts to share their tips for overcoming those difficulties. Our experts discuss these challenges, and the solutions proven to resolve them. Register Now.

Big Challenges for Small Sponsors: Competition in Oncology Research

Every biopharma sponsor faces the challenge of initiating, running and closing trials on time, but oncology studies pose several unique hurdles. Read our new whitepaper to learn more about how sponsors can gain a competitive edge in oncology trials. Download now. 

Getting your global, small molecule CMC regulatory strategy right from the start
Thursday, September 30, 2021 | 11am ET / 8am PT | Thermo Fisher Scientific

Navigating each phase of your small molecule’s journey with the right CMC strategy is a critical component to enable success. Register Now.

Explore the Depths of Radiomic Data in Clinical Trials
Live & Recorded On: Monday, September 27, 2021 | 2pm ET / 11am PT | HealthMyne

Join this interactive panel to explore the depths of radiomic data in clinical trials. Learn real world applications and practical strategies for radiomic use in clinical trials, personalized drug development and therapy response. Register Now.

Take Rebates and Accruals from Administrative Burden to Competitive Advantage
Model N

This white paper will help you understand how you can streamline your rebate and accrual management processes to improve visibility, eliminate inefficiencies, align rebate programs, and optimize revenue. Download Now.

Eliminating Problems in Drug Development - Understanding the Role of Drug Metabolism
Thursday, September 23, 2021 | 1pm ET / 10am PT | SEKISUI XenoTech

This talk will discuss processes for the metabolism of a drug, referred to as ADME, and the safety testing to provide requisite information to move a drug through IND and into clinical trials. Prior to marketing a new drug and actually prior to administering a candidate drug to humans in clinical trials, it is important to ensure that drug will not only be effective in the therapeutic manner prescribed, but also be safe and not bring any undo harm to patients. If you are involved in the development of potential new therapeutics, this discussion will help you gain necessary knowledge to inform your drug development decisions. Register Now.

Bespoke & flexible cell line development programs from gene to clinic
Thursday, September 23, 2021 | 11am ET / 8am PT | Lonza

To learn how you can chart an optimal path from gene to the clinic by tailoring your cell line development program to match your molecule type, timelines, yield requirements and risk priorities, register for our webinar now.

De-risk injectable drug development using elastomer barriers and films
Wednesday, September 22, 2021 | 11am ET / 8am PT | West Pharmaceutical Services

Did you know that not all elastomeric component surface barriers are created equal? Gain insight from West experts, Fran DeGrazio and Peggy Frandolig, in a free webinar on September 22. Register Now.

Becoming the early bird - Establishing a dialogue with the FDA around accelerating preclinical research
Live & Recorded on: Tuesday, September 21, 2021 | 11am ET / 8am PT | Thermo Fisher Scientific

This webinar will bring together experts in preclinical trial design, R&D efficiency and regulatory affairs to offer advice on how companies can best engage the FDA early in the research process. Topics include strategies for determining the best timeline for approaching the FDA with a new drug candidate, a review of new technologies designed to speed up preclinical testing, and ensuring the proper balance between streamlining preclinical research and gathering enough data to satisfy regulators. Register Now.

Building a data strategy that goes beyond the data lake
Recorded on Tuesday, September 21, 2021 | Innovaccer & AWS

A data lake is a great first step to transforming real world data into real world evidence that can be trusted to make critical decisions that drive forward the life changing therapies that you bring to patients today and tomorrow. During this webinar, hear from ex-CTO of Kaiser Permanente, ex- Data strategy leader of Merck, AWS Cloud Life Science leader and the LS product leader from Innovaccer on why we all need to think ‘beyond the data lake’. Save Your Spot.

Proven Quality - Preventing quality issues during drug development
Recorded on Monday, September 20, 2021 | Catalent

Many drug developers naturally turn to contract manufacturers, but even with the best, they need to stay deeply involved, and aware of what is happening with their CDMO. A manufacturing plant that runs into FDA concerns, even for something unrelated to your efforts, can still delay years of work and the rewards of a drug approval. We’ll look at the diverse set of tactics companies can use to forestall manufacturing disappointments, from recruitment to partnerships to regulatory communication and more. Register Now.

“GMP-Like” Plasmid Services & Their Role in Gene & Cell Therapy
Fierce Life Sciences Custom Publishing

“GMP-Like” plasmid services are rapidly expanding in cell & gene therapy. Understanding what value this creates is important as suppliers innovate to support researchers through the stages of clinical development. Please take a short survey to provide clarity to the value proposition it may provide.

Cell Therapy: How to Avoid Clinical Trial Pitfalls and Bring Products to Market Quickly

Cell therapies represent a burgeoning area of clinical research and given the current number of new INDs the FDA expects 10-20 cell and gene therapies approved annually by 2025¹. This white paper explores common pitfalls in the clinical development of these complex therapies, lessons learned and best practices supporting accelerated approvals and reduced costs. Download Now.

Rethink your commercialization strategy
Thursday, September 16, 2021 | 11am ET / 8am PT | AmerisourceBergen

Is it time to rethink your approach to commercialization? Learn how the right partner and mix of solutions can put you on the path to delivering disruption innovation. Register Now.

Next Best for Account Management - It’s not just for Omnichannel anymore
Recorded on Thursday, September 16 | IQVIA

In this webinar, we will look into how Next Best programs can be leveraged to support account-based engagement models, and consider the right opportunities to leapfrog industry leaders by enhancing proven models with technology-based coordination and insights-led decision processes. Register now.

Improving Patient Outcomes with Real-Time Medication Adherence Technology

COVID-19 has changed the way healthcare is delivered and taught consumers the benefits of technology-enabled continuous connectivity with their physicians, care teams and pharmacies. This enhanced connectivity creates opportunities to make progress on some of the health system’s most difficult problems, such as the issue of medication nonadherence, which compromises health outcomes for patients across a wide range of conditions. Download now.

Paid Marketplace
Infographic: Bridging the Cell and Gene Therapy Gap Between Manufacture and the Supply Chain

Bringing Cell, gene-modified cell and gene therapies successfully through the clinical trial process introduces a level of supply chain risk, complexity and specialized requirements which are not yet fully understood. This infographic focuses on taking a closer look at unique clinical supply challenges and unique needs associated with cell and gene therapies. Download to Learn More.

Real-world data to precisely message HCPs across all marketing channels
Wednesday, September 15, 2021 | 1pm ET / 10am PT | Prognos Health

Pharma brand managers have moved from traditional marketing models for many reasons. However, the now favored Omnichannel approach has been difficult to implement because it requires the discipline of a cross-channel strategy that seamlessly integrates content to provide consistency across multiple “buyer” physician touchpoints. This webinar covers how RWD can accelerate executing on a true omnichannel outreach. Register now.

Considerations and Guidelines for Real-Time qPCR Optimization

This White Paper provides an introduction to real-time qPCR and discusses the different approaches to real-time qPCR, outlines considerations to help you quickly compare previously optimized qPCR assays with a new qPCR Master Mix, offers guidance for optimizing your real-time qPCR assay, and provides a tool for comparing qPCR reagent formulations. Download Now.

Removing Antibody Drug Discovery's DNA Bottleneck
Recorded on Tuesday, September 14, 2021 | Twist Bioscience

G protein-coupled receptors (GPCRs) are one of the most promising drug targets due to their pathophysiological role in the human body. However, at the same time, GPCRs have proven to be one of the most challenging targets for antibody drug development. This webinar will describe the use of next-generation DNA synthesis tools to overcome the DNA bottleneck in antibody-based GPCR drug discovery, the discovery and creation of both antagonistic and agonistic GLP-1R antibodies by panning this GPCR-focused phage display library on a GLP-1R overexpressing Chinese hamster ovary cell line, and more. Register Now.

Executive Summary
Mapping the Pathway to Designing Successful Treatments

To produce a drug product with ideal biopharmaceutical properties, formulators must understand the molecule’s characteristics and create optimal formulations by utilizing technologies and processes that address the unique challenges presented by each API. But accelerating drug development timelines can force innovators to opt for quick-to-clinic dosage form approaches which may lead to suboptimal performance in patients. Download this Executive Summary to learn more.

Engaging Key Medical Device Stakeholders with Compliant Virtual Technology

In this paper, readers will learn what hybrid virtual engagement looks like, how to match virtual engagement tactics with different meeting and audience types, how to incorporate virtual elements into face-to-face interaction, beyond table stakes like cost reduction and increased participation, the meaningful benefits of engaging virtually, and the foundational elements of a virtual-first strategy for medical device organizations. Download Now.

Applications of Digital Twins in Clinical Trials for Alzheimer’s Disease
Unlearn AI

Read Unlearn’s whitepaper to learn about how novel trial designs with Digital Twins enable more efficient clinical trials, with higher power and smaller required sample sizes. Download now. 

Building Trust with ELISA Manufacturers: Bridging the Gap Between Necessity and Efficiency

For decades, scientists have used sandwich ELISA assays as a reliable tool for understanding disease mechanism, progression, and prognosis. Download this paper now to learn which ELISA features are most important to scientific researchers in 2021, the impact of in-house validation studies to research workflows, and specifications to consider when purchasing ELISA assays for your research. Download Now.

Avoiding pitfalls in sterile manufacturing
Recorded on Thursday, September 9, 2021 | Grand River Aseptic Manufacturing

While the rapid development of COVID-19 vaccines helped to wind down the pandemic, it also brought to light the many challenges involved in ramping up the production of injectables that must be made in sterile, aseptic environments. Several companies struggled to compress what’s normally a year-long process of getting up to speed into a matter of months. Such pitfalls can be avoided, however, by improving planning processes and adopting new technologies to streamline manufacturing. Register Now.

Effective Scale-Up and Technology Transfer Strategies for Spray Dried Pharmaceutical Products
Wednesday, September 8, 2021 | 11am ET / 8am PT | Catalent

This webinar features a Catalent expert presenting a roadmap for formulation and process development that can aid in seamless scale-up. Another expert from EuroAPI will provide an overview of typical tech transfer and scale-up processes, highlighting how thermodynamic modelling, engineering modifications, API conservation and cleaning techniques in large scale settings can help optimize overall processes in terms of yield and run times. Register now.

Applying Experience - Partnering with Pioneers to Deliver Plasmid for Discovery Through Commercial Application
Tuesday, September 7, 2021 | 11am ET / 8am PT | Aldevron

Engage with experts in gene therapy to learn about important considerations, the necessity of a strong plan for plasmid at the early stages of candidate development, and potential obstacles. Panel experts join Aldevron to discuss how continuity and consistency are crucial for commercialization. Learn about the original GMP-Source® service, developed in collaboration with leading gene therapy researchers, and how this continues to enable early phase clinical research. Register Now.

What pandemic-related shifts in patient preferences mean for marketers
Phreesia Life Sciences

Shifts toward convenience, flexibility, personalization and technology-enabled experiences for patients are here to stay—and this white paper explores how those seismic changes present significant opportunities for pharma marketers to meet and engage patients more effectively. Download Now.

The Value of Precision Medicine Informatics Initiatives Research Findings

Download the Value of Precision Medicine Informatics (PMI) Initiatives report to learn about the technology, data types, and the value derived from more than 100 PMI initiatives. Download now. 

High-yield NK cell culture for allogeneic cell therapy applications
Thermo Fisher Scientific

​​​​​​Read about expansion and characterization of NK cells grown in a feeder-free culture system using Gibco™ CTS™ NK-Xpander™ Medium, which can support an average of 1,500-fold expansion of NK cells within two weeks. Download the white paper now.  

Challenging Tradition: The Argument for Integrated Commercialization to Improve Operational Agility

Paper discusses how today’s economics do not allow manufactures to keep making decisions in an antiquated way. They need to challenge tradition, adapt to market demands and external forces out of their control; in order to deliver faster, cheaper, more successful launches rooted in integrated commercialization and operational agility. Download now.

Five Trends to Watch in the European Market Access Environment
Blue Matter

This white paper provides a concise overview of the trends currently shaping the market access environment in Europe, as well as the implications for biopharma companies. Download now. 

MDR conform development of sterile Medical Devices
Recorded on Wednesday, September 1, 2021 | Fresenius Kabi

The Webinar will cover challenges of MDR for sterile medical device manufacturing companies, phases of Design Control for the development process of sterile disposable medical devices, advantages of a one-stop-shop during development and production in MDR environment, and contract Manufacturing partnership. By attending the webinar, you will get insight on MDR requirements and their impact on the development of medical devices, relevance of adequate documentation during MDR conform development of sterile medical devices, and advantages of Contract Manufacturing as strategic partnership to fulfill MDR requirements--especially for pharmaceuticals companies. Register Now.

Evaluating current manufacturing platforms for recombinant AAV production
Patheon by Thermo Fisher Scientific

Realizing the full potential of viral vector-based therapies requires a successful manufacturing platform for AAV vectors. In this whitepaper, compare differences between AAV platforms and the pros and cons of each to help evaluate which option is best suited for your gene therapy. Download now.

Going from Process R&D to Clinical APIs Quickly and Effectively
Cascade Chemistry by Aceto

Pharmaceutical companies driving an active ingredient to clinical trials need an API CDMO that overcomes challenges with creative problem-solving and a high level of flexibility. This white paper explores how to move from process R&D to clinical APIs quickly and effectively with the right CDMO. Read more now.

Preparing for an evolving regulatory landscape to successfully commercialize cell and gene therapies
Tuesday, August 31, 2021 | 11am ET / 8am PT | Thermo Fisher Scientific

Monica Commerford, Ph.D., Head of Regulatory Affairs at Thermo Fisher Scientific, discusses the strategies available to meet critical regulatory requirements to accelerate early to late state CMC product development. Register Now.

The Future of Clinical Services
Fierce Pharma

This survey examines the life science industry’s progress in reducing system and process complexity to improve data transparency, study execution, and simplify how partners work together throughout the trial lifecycle. The goal of this research is to understand the drives, benefits, and barriers of a unified and connected clinical operating model. Take the survey.

Accelerate late-phase drug development with continuous manufacturing
Wednesday, August 25, 2021 | 11am ET / 8am PT | Thermo Fisher Scientific

Continuous manufacturing enables late-phase development by ensuring quality assurance and reducing API usage. Attend this webinar to learn how to create a strategy that reduces total cost of ownership. Register Now.

Let A Digital Sherpa Uncomplicate The Path for Patients
Recorded on Wednesday, September 15 | ConnectiveRx

The path to starting a prescription can be complicated. Patients need a guide that empowers them with information to understand the steps along the way. Leverage a patient's mobile device and, voila, there's a digital Sherpa in the palm of their hand. Register now. 

Today’s View - How patients engage in social networks
Recorded on Tuesday, August 24, 2021 | MyHealthTeams

How do today’s patients engage in social networks? Learn what’s working for innovative health marketers as consumers facing chronic health conditions re-think the relationships and resources that help them manage their disease. Register now.

How lessons learned from the COVID pandemic will improve vaccine development in the future
Recorded on Wednesday, August 11, 2021 | Catalent

During the COVID-19 pandemic, several pharma companies moved so fast to develop vaccines that the amount of time between the sequencing of the virus to the introduction of the first three vaccines was less than a year. This Fierce webinar will include input from vaccine R&D professionals, including experts in clinical trial design, regulatory affairs and manufacturing. They will draw upon their own experiences in vaccine development to offer tips for incorporating elements of the successful COVID-19 vaccine rollout into future vaccine programs. Register Now.

Get solutions to market faster

Secure regulated and non-regulated content, keep data GxP compliant, and simplify how teams work together. Download eBook now. 

The Future of Clinical Monitoring
Recorded on Wednesday, July 28 | IQVIA

Risk-based, Remote, Centralized Monitoring – all can play a critical role in clinical trials, but which is right for your study? If you are responsible for a clinical trial, leading clinical operations, project management, outsourcing, or clinical monitoring, learn about the breadth of technology choices and what you should consider to determine the ideal solution for your unique study needs. Register now.

COVID-19 Virus Sequencing for Drug Development
Recorded on Wednesday, July 28, 2021 | Labcorp Drug Development

In this webinar, we will establish the medical backdrop for COVID-19 virus sequencing in drug development, connect insights from population surveillance to potential solutions for drug developers, describe the biological relevance of sequencing in drug development, and outline approaches to COVID-19 virus sequencing, including the application of both targeted and whole genome sequencing to drug development. Register now!

How to Optimize In Vitro and In Vivo Data Analysis and Data Management in Drug Research

This whitepaper explores how powerful, fast and modern, modular architecture, combined with interactive data management, visualization and analysis platform can accelerate the entire discovery and research process. This resource is helpful for companies that are looking to help scientists and research IT teams to reclaim months of their time usually spent on manual steps to bridge gaps in their current software or reinventing the wheel while trying to optimize their lab and IT processes. Learn More.

New trends in virtual trials
Recorded on Monday, July 26, 2021 | Catalent

In November, clinical trial platform developer Medable raised $91 million in private funding, amid the COVID-19 pandemic that touched off huge demand among pharmaceutical companies looking to initiate “siteless” or virtual clinical trials. This webinar will explore the role of CROs in siteless trials and the opportunities and challenges for CROs to expand their capabilities in this burgeoning area. Register now.

Revolutionizing Commercial Operations: The Power of People, Process, and Technology
Recorded on Thursday, July 22, 2021 | Model N

In today’s complex market, emerging and mid-size pharmaceutical manufacturers require the expertise and supporting technologies, across multiple disciplines, to effectively maximize product revenue and optimize market access functions. Join us on July 22, as industry expert, Tracy Mumpower, shares strategies for integrating a Business Service operations model with your Commercial and Market Access teams, to continue to drive operational excellence and insights through the power of People, Process, and Technology. Register Now.

How Digital Transformation Can Lead the Evolution of Pharmaceutical Operations
Salesforce and Copado

Pharmaceutical companies are continuing to rethink how they develop, make and distribute medicines to position themselves for success in the post-pandemic environment. The pandemic showed they need more nimble technology stacks that enable them to pivot at scale and continue to adapt their operations to challenges and opportunities. Learn how low-code enterprise systems give pharma companies more capability AND more flexibility when combined with modern Development Operations suites and tools. Download now.

Opportunities for Expanding usage of Real-World Data across the Oncology Product Development Life Cycle
Recorded on Thursday, July 15, 2021 | Ontada

Real-world data are currently supporting decision making across the spectrum of oncology care.  Join us as we discuss the current paradigm of oncology product development life cycle and the use of real-world oncology data to drive innovation, efficiencies, and improvements in patient outcomes. Register now.

Five Common Mistakes in Panel Management
Recorded on Wednesday, July 14, 2021 | SurveyHealthcareGlobus

It takes time and focus to keep your panel in good health. By learning common pitfalls, this webinar will assist you in refining your panel management strategy and best practices to keep your respondents motivated and engaged. Register now.

How MOMA Therapeutics Drives World Class Lead Discovery In The Cloud
Recorded on Monday, July 12, 2021 | PerkinElmer

In this webinar hear from “both sides of the house” – first from an innovative information technology leader and then a senior scientist who uses the solutions provided by IT.  Learn how MOMA Therapeutics’ innovative lead discovery solution can be applied to the needs of your biotechnology discovery workflows. Save Your Spot.

Integrating Wearable Biosensor Technologies into Clinical Studies

Wearable biosensors are transforming clinical research to the benefit of patients, sites and sponsors alike. This whitepaper discusses the challenges and considerations Sponsors need to consider before they can realize the promise of wearable biosensors. Download Now.

Integrating Life Sciences and Digital Technology to Transform Therapeutic Research and Development
Dell Technologies

COVID-19 showed us the potential and need for radical improvement in the life sciences industry. Pandemic programs reset expectations for how quickly drugs and vaccines can reach patients with unprecedented R&D timelines. Changing patient expectations and technology are catching up with industry needs, setting the stage for a period of transformation that will accelerate the development of life-changing medicines. Download now.

The Interconnected World of Pricing, Market Access, and Value-Based Decision Making
Recorded on Wednesday, June 30, 2021 | Deloitte

Biopharmaceutical drug pricing and market access contracting have become more complicated and interrelated than ever. Join us to discuss how a more integrated, intuitive approach to pricing and contracting can create organizational agility. Discover how this inter-connected approach can have a radical impact on the profitability of life sciences organizations as well as align incentives across the health care ecosystems. Register now.

Advancing Innovative Drug Discovery by DNA Encoded Library and FBDD/SBDD methods
Recorded on Wednesday, June 30, 2021 | HitGen & Vernalis

HitGen has established an industry-leading drug discovery platform for small molecules and nucleic acid drugs centered on the design, synthesis and screening of DNA encoded chemical libraries (DELs), fragment-based drug discovery (FBDD) and structure-based drug design (SBDD) technologies. HitGen founder Dr. Jin Li and Vernalis chief scientist Professor Rod Hubbard will join hands to illustrate advancing innovative drug discovery by DNA Encoded Library and FBDD/SBDD methods. Register Now.